Skip to content
10-K

Annual Report

AVID BIOSERVICES, INC.

0001683168-24-004610

← back to feed
Filed
Jul 2, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jun 24, 2024 63.58M sh
Shares Diluted FY 2024 · Apr 30, 2024 63.2M sh
Capex FY 2024 · Apr 30, 2024 $31.81M
Operating Cash Flow FY 2024 · Apr 30, 2024 $10.95M
Long Term Debt FY 2024 · Apr 30, 2024 $54.24M
Cash And Equivalents FY 2024 · Apr 30, 2024 $38.11M
Stockholders Equity FY 2024 · Apr 30, 2024 $60.89M
Current Liabilities FY 2024 · Apr 30, 2024 $70.57M
Total Liabilities FY 2024 · Apr 30, 2024 $275.67M
Current Assets FY 2024 · Apr 30, 2024 $104M
Total Assets FY 2024 · Apr 30, 2024 $336.56M
Eps Diluted FY 2024 · Apr 30, 2024 −$2.23
Eps Basic FY 2024 · Apr 30, 2024 −$2.23
Sga Expense FY 2024 · Apr 30, 2024 $26M
Net Income FY 2024 · Apr 30, 2024 −$140.75M
Operating Income FY 2024 · Apr 30, 2024 −$18.68M
Gross Profit FY 2024 · Apr 30, 2024 $7.32M
Revenue FY 2024 · Apr 30, 2024 $139.91M